Anthony G. De Soyza

Newcastle Upon Tyne, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 166 publications

Qualitative exploration assessing the acceptability of shared decision-making for prescribing airway clearance techniques in adults with bronchiectasis.

Qualitative exploration assessing the acceptability of shared decision-making for prescribing airway clearance techniques in adults with bronchiectasis.

Journal: BMJ open

Published: July 28, 2026

The frequent exacerbator phenotype in bronchiectasis revisited: Data from EMBARC registry.

The frequent exacerbator phenotype in bronchiectasis revisited: Data from EMBARC registry.

Journal: American journal of respiratory and critical care medicine

Published: April 01, 2026

Unsupervised home spirometry versus supervised clinic spirometry: analysis of longitudinal participant-level data from the CLEAR trial in patients with bronchiectasis.

Unsupervised home spirometry versus supervised clinic spirometry: analysis of longitudinal participant-level data from the CLEAR trial in patients with bronchiectasis.

Journal: Thorax

Published: April 01, 2026

Resource impact of bronchiectasis and associated exacerbations: based on a 5-year prospective observational cohort study (BronchUK).

Resource impact of bronchiectasis and associated exacerbations: based on a 5-year prospective observational cohort study (BronchUK).

Journal: BMJ open respiratory research

Published: March 06, 2026

Phase III LUNA clinical programme: design of four randomised, double-blind, placebo-controlled studies assessing the efficacy and safety of tozorakimab in patients with symptomatic COPD and a high risk of exacerbations.

Phase III LUNA clinical programme: design of four randomised, double-blind, placebo-controlled studies assessing the efficacy and safety of tozorakimab in patients with symptomatic COPD and a high risk of exacerbations.

Journal: BMJ open respiratory research

Published: February 23, 2026

Mucoactive agents in bronchiectasis: a systematic review and meta-analysis.

Mucoactive agents in bronchiectasis: a systematic review and meta-analysis.

Journal: European respiratory review : an official journal of the European Respiratory Society

Published: January 14, 2026

Comorbid diabetes disease severity and microbial changes in patients with bronchiectasis: a combined analysis of data from the EMBARC, EMBARC-India, Australian, and BE-China registries.

Comorbid diabetes disease severity and microbial changes in patients with bronchiectasis: a combined analysis of data from the EMBARC, EMBARC-India, Australian, and BE-China registries.

Journal: The Lancet. Respiratory medicine

Published: December 23, 2025

Investigating prognostic classifications of preexisting multiple long-term conditions for health outcomes 1 year after COVID-19 hospitalization: A UK prospective observational study.

Investigating prognostic classifications of preexisting multiple long-term conditions for health outcomes 1 year after COVID-19 hospitalization: A UK prospective observational study.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: December 16, 2025

Investigating prognostic classifications of pre-existing multiple long-term conditions for health outcomes one-year after COVID-19 hospitalisation: a UK prospective observational study.

Investigating prognostic classifications of pre-existing multiple long-term conditions for health outcomes one-year after COVID-19 hospitalisation: a UK prospective observational study.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: December 16, 2025

Implementation and outcomes of drug response assessments for inhaled hypertonic saline in bronchiectasis: a post hoc analysis of the CLEAR trial.

Implementation and outcomes of drug response assessments for inhaled hypertonic saline in bronchiectasis: a post hoc analysis of the CLEAR trial.

Journal: Thorax

Published: November 27, 2025

The association between chronic rhinosinusitis, bronchiectasis and type 2 inflammation: an EMBARC registry analysis.

The association between chronic rhinosinusitis, bronchiectasis and type 2 inflammation: an EMBARC registry analysis.

Journal: ERJ open research

Published: October 10, 2025

Hypertonic Saline or Carbocisteine in Bronchiectasis.

Hypertonic Saline or Carbocisteine in Bronchiectasis.

Journal: The New England journal of medicine

Published: September 29, 2025

Showing 1-12 of 166

Last Updated: 09/26/2026